the aid library

LIST OPTIONS

Filter

9581

Periods in a Pandemic Menstrual hygiene management in the time of COVID-19

Plan International (2020) CC

This report looks at how the current implications of COVID-19 is exacerbating key challenges for people who menstruate around the world and provides recommendations on how to include menstrual hygiene management (MHM) within a COVID-19 response.

Ethiopia Country Card –2017 10 EN

Handicap International Handicap International (2017) C1

MANDATEHandicap International in Ethiopia aims at promotinginclusive access to humanitarian aid and development sectors for the most vulnerable groups, including people with disabilities. This includes providing access to services by supporting equal opportunities for people w... more

Download (116)

View PDF (150)

WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment

World Health Organization WHO (2020) C_WHO

The 2020 recommendations for the programmatic management of TB preventive treatment are the first to be released under the rubric of WHO consolidated TB guidelines (Module 1 – Prevention). The WHO consolidated TB guidelines will gradually group all TB recommendations and will be complemented by ma... more

Download (236)

View PDF (169)

Social Costs of the COVID-19 Pandemic

P. Pereznieto; I. Oehler The Independent Panel (2021) CC

Background paper 9 The Independent Panel for Pandemic Preparedness and Response May 2021

Download (159)

View PDF (187)

Human Rights Dimensions of the COVID-19 Pandemic

J. Bueno de Mesquita; A. Kapilashrami; B. Mason Meier The Independent Panel (2021) CC

Background paper 11 The Independent Panel for Pandemic Preparedness and Response May 2021

Download (161)

View PDF (211)

My hero is you 2021- How kids can hope with COVID-19
recommended

Inter-Agency Standing Committee IASC; World Health Organization (WHO); UNICEF; et al. (2021) C_WHO

The story-book, a sequel to the immensely successful ‘My Hero is You: How kids can fight COVID-19!’, is being released in the second year of the COVID-19 pandemic. The new story, aimed primarily at children aged 6-11 years, sees the return of Ario, a fantasy creature who travels the world helpin... more

Botswana National Integration Guidelines

United Nations Population Fund UNFPA (2022) C1

This Guideline, the first for the country, draws from national health sector reforms and integration agenda as outlined in the key national strategic documents. The Guide applies lessons learnt from the SRH/HIV Linkages project and its scale-up; other national experiences and from regional and globa... more

Technical series on adapting to climate-sensitive health impacts: Diarrhoeal diseases

World Health Organization WHO (2023) C_WHO

This guide presents a basis for understanding how diarrhoeal diseases are currently influenced by climate and weather, and may be further exacerbated by climate change. It is a technical guide on how to conduct a Vulnerability & Adaptation assessment for diarrhoeal diseases and climate change, and p... more

Download (285)

View PDF (384)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Health Sector Disaster Recovery Framework Guide

UN Development Programme; World Health Organization WHO (2023) CC

The Disaster Recovery Framework (DRF) Guide for the Health Sector provides guidance on how to implement a comprehensive, integrated, and structured approach to disaster recovery. Its overarching goal is to minimize the impact of the disaster on communities and help countries to recover quickly and e... more

Download (222)

View PDF (321)

Healing personal trauma to restore communities

Catholic Relief Services CRS (2016) C1

Integrating trauma healing for partner staff into recovery programming. This assessment shares testimonies from CRS and partner staff who participated in a trauma healing program in Central Africa Republic. CRS's trauma-healing methodology uses small groups—of all genders, ages and faiths—focu... more

Download (120)

View PDF (147)

Strengthening and sustaining the fight against HIV and AIDS through public e- procurement - The case study of Ukraine

Transparency International Ukraine; Hivos people unlimited; Network 100percent life (2018) C2

Compiled by Tin Geber for HIVOS. London, March 2018

Download (238)

View PDF (175)

COVID-19: IPC Simulation Exercise

World Health Organisation (WHO) Health Emergencies Programme (2020) C_WHO

General Objectives 1. Share information on practices on IPC for endemic colonization in a tertiary facility and how those precautions could evolve based on the progress of the event, then further integrating response capabilities, plans and procedures to triage and implement source control measure... more

Global Appeal 2021 update

UNHCR The UN Refugee Agency (2021) CC

The Global Appeal provides updated information for government, private donors, partners and other readers interested in UNHCR's priorities and budgeted activities for 2021 to protect and improve the lives of tens of millions of people of concern (refugees, internally displaced people, stateless pers... more

Multi-country outbreak of mpox, External situation report #42- 9 November 2024

World Health Organisation (WHO) (2024) C_WHO

This is the 42nd situation report for the multi-country outbreak of mpox, which provides an update on the epidemiological situation of mpox in Africa (including countries in the WHO African Region and some countries in the WHO Eastern Mediterranean Region), with data as of 3 November 2024.

Revised National Guidelines on Mpox

Wasif Malik, M.; et al. National Institute of Health, Pakistan (2024) CC

This document serves to provide interim guidance/ recommendations to carry out mpox surveillance activities mainly case investigation, contact tracing and isolation. For the development of this document WHO, UKHSA and CDC guidelines were referred to and adopted within the country context.

Download (632)

View PDF (1320)

WHO malaria terminology, 2021 update

World Health Organization WHO (2021) C_WHO

This updated glossary for malaria aims to improve communication and mutual understanding within the scientific community, as well as with funding agencies, public health officials responsible for malaria programmes, and policy-makers in malaria-endemic countries

Download (1172)

View PDF (1996)

Konsensus Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia

Indonesian Society of Internal Medicine (2006) C1

Guidelines and Consensus for the Diagnosis, Management and Prevention of Type 2 Diabetes Mellitus in Indonesia

Antimicrobial Resistance Benchmark 2020

Access to Medicine Foundation (2020) C2

The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread. We have reac... more

Terminología del paludismo de la OMS, actualización de 2021

Organización Mundial de la Salud OMS (2021) C_WHO

My hero is you 2021- How kids can hope with COVID-19 recommended

My hero is you 2021- How kids can hope with COVID-19
recommended